Fenwick & West represented Coinbase Global, Inc. in the offering. Coinbase Global, Inc. (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the...
You must be a Standard 1 Year member to access this content.
Fenwick & West and Sidley Austin are representing Impel Pharmaceuticals Inc. in the transaction. JN BIDCO LLC announced the acquisition of Impel Pharmaceuticals Inc. (OTCQX: IMPL)....
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Wonder Group in the transaction, and Wilmer Cutler Pickering Hale and Dorr represented Blue Apron Holdings. Wonder Group (“Wonder”) announced that it has...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Shockwave Medical, Inc. in the transaction. Shockwave Medical, Inc. (Nasdaq: SWAV) announced its $750 million offering of 1.00% convertible senior notes due 2028...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Chinook Therapeutics, Inc. on the transaction, while Hogan Lovells US LLP represented Novartis AG. Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company, announced...
You must be a Standard 1 Year member to access this content.
Fenwick represented Third Harmonic Bio, Inc. on the deal. Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT...
You must be a Standard 1 Year member to access this content.
Fenwick represented zSpace, Inc. on the deal. zSpace, Inc., a leading augmented and virtual reality educational technology platform, announced its definitive merger agreement with EdtechX Holdings Acquisition...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised DICE Therapeutics on the deal. DICE Therapeutics (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Coinbase on the deal. Coinbase Global, Inc. (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the cryptoeconomy, announced its...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Bill.com on the deal. Bill.com (NYSE: BILL), a leading provider of cloud-based software that simplifies, digitizes and automates complex back-office financial...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented the initial purchasers in the offering. Independence Energy Finance LLC, a wholly-owned subsidiary of Independence Energy LLC (“Independence Energy”), executed its offering of $500...
You must be a Standard 1 Year member to access this content.
